The Zur Rose Group announced a collaboration with Novo Nordisk to support people living with obesity which will begin in Germany in the first quarter of 2021 with the intention to expand across European markets. This collaboration sees the European eHealth provider and the global healthcare company combining their digital ecosystem and obesity expertise, respectively, to raise awareness of obesity and to improve access to information, diagnosis and care. Via the Zur Rose Group platforms, people living with obesity will gain convenient access to an array of actionable healthcare services.

The focus of the collaboration will be the development of a new digital hub including information on treatment options and solutions available for obesity. People living with obesity will also gain access to tangible support, and digital solutions such as help to locate a physician for a face-to-face visit or an online consultation (via TeleClinic's telemedicine service) and a high-value range of treatment options which they can obtain either at a brick-and-mortar pharmacy or at an online pharmacy.